Shanghai Fosun Pharmaceutical (Group) Co (Shanghai Fosun Pharmaceutical (Group) Co) Other Long-Term Liabilities : $1,030 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities?

Shanghai Fosun Pharmaceutical (Group) Co's other long-term liabilities for the quarter that ended in Mar. 2024 was $1,030 Mil.

Shanghai Fosun Pharmaceutical (Group) Co's quarterly other long-term liabilities increased from Sep. 2023 ($992 Mil) to Dec. 2023 ($1,056 Mil) but then declined from Dec. 2023 ($1,056 Mil) to Mar. 2024 ($1,030 Mil).

Shanghai Fosun Pharmaceutical (Group) Co's annual other long-term liabilities increased from Dec. 2021 ($928 Mil) to Dec. 2022 ($991 Mil) and increased from Dec. 2022 ($991 Mil) to Dec. 2023 ($1,056 Mil).

Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Shanghai Fosun Pharmaceutical (Group) Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co (Shanghai Fosun Pharmaceutical (Group) Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (OTCPK:SFOSF) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

02196:Hong Kong 08HH:Germany 08HH:Germany 600196:China

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.